Live-cell imaging of tumor proteolysis: impact of cellular and non-cellular microenvironment.
暂无分享,去创建一个
Bonnie F. Sloane | K. Moin | J. Rothberg | M. Sameni | Mansoureh Sameni | Kamiar Moin | Jennifer M Rothberg | Bonnie F Sloane
[1] A. Klein-Szanto,et al. Transformation of Human Breast Epithelial Cells by c‐Ha‐ras Oncogene , 1991, Molecular carcinogenesis.
[2] X. Puente,et al. Human and mouse proteases: a comparative genomic approach , 2003, Nature Reviews Genetics.
[3] Y. DeClerck. Interactions between tumour cells and stromal cells and proteolytic modification of the extracellular matrix by metalloproteinases in cancer. , 2000, European journal of cancer.
[4] C. López-Otín,et al. Loss of collagenase-2 confers increased skin tumor susceptibility to male mice , 2003, Nature Genetics.
[5] R. Gillies,et al. Vacuolar-type H(+)-ATPases are functionally expressed in plasma membranes of human tumor cells. , 1993, The American journal of physiology.
[6] C. López-Otín,et al. Emerging roles of proteases in tumour suppression , 2007, Nature Reviews Cancer.
[7] S. Stylli,et al. Invadopodia: At the cutting edge of tumour invasion , 2008, Journal of Clinical Neuroscience.
[8] Bonnie F. Sloane,et al. Phorbol Ester Activation of a Proteolytic Cascade Capable of Activating Latent Transforming Growth Factor-β , 2002, The Journal of Biological Chemistry.
[9] M. Bissell,et al. The dominance of the microenvironment in breast and ovarian cancer. , 2002, Seminars in cancer biology.
[10] Roberto Buccione,et al. Foot and mouth: podosomes, invadopodia and circular dorsal ruffles , 2004, Nature Reviews Molecular Cell Biology.
[11] Bonnie F. Sloane,et al. Mutant K-ras regulates cathepsin B localization on the surface of human colorectal carcinoma cells. , 2003, Neoplasia.
[12] E. Petricoin,et al. Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. , 2005, The Journal of clinical investigation.
[13] E. Rofstad,et al. Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. , 2006, Cancer research.
[14] M. Shekhar,et al. Host microenvironment in breast cancer development: Extracellular matrix–stromal cell contribution to neoplastic phenotype of epithelial cells in the breast , 2003, Breast Cancer Research.
[15] Stephen J. Weiss,et al. Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited , 2009, The Journal of cell biology.
[16] C. Gialeli,et al. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting , 2011, The FEBS journal.
[17] B. Nielsen,et al. Stromal cells associated with early invasive foci in human mammary ductal carcinoma in situ coexpress urokinase and urokinase receptor , 2007, International journal of cancer.
[18] Bonnie F. Sloane,et al. Lysosomal cathepsin B participates in the podosome-mediated extracellular matrix degradation and invasion via secreted lysosomes in v-Src fibroblasts. , 2008, Cancer research.
[19] O. Vasiljeva,et al. Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer. , 2006, Cancer research.
[20] R. Stern,et al. CD44 Interaction with Na+-H+ Exchanger (NHE1) Creates Acidic Microenvironments Leading to Hyaluronidase-2 and Cathepsin B Activation and Breast Tumor Cell Invasion* , 2004, Journal of Biological Chemistry.
[21] S. Okushiba,et al. Overexpression of caveolin‐1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage , 2002, Cancer.
[22] M. Walker,et al. Endo180 expression with cofunctional partners MT1-MMP and uPAR-uPA is correlated with prostate cancer progression. , 2009, European journal of cancer.
[23] I. M. Neiman,et al. [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.
[24] W. Sessa,et al. Distinct Roles of Endothelial and Adipocyte Caveolin-1 in Macrophage Infiltration and Adipose Tissue Metabolic Activity , 2011, Diabetes.
[25] F. Miller,et al. MCF10AT: a model for the evolution of cancer from proliferative breast disease. , 1996, The American journal of pathology.
[26] Jayanta Debnath,et al. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. , 2003, Methods.
[27] Mina J Bissell,et al. Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes , 2003, Breast Cancer Research.
[28] J. Pollard,et al. Colony stimulating factor-1 is required to recruit macrophages into the mammary gland to facilitate mammary ductal outgrowth. , 2002, Developmental biology.
[29] Gregory S Karczmar,et al. MRI of the tumor microenvironment , 2002, Journal of magnetic resonance imaging : JMRI.
[30] T. Acott,et al. Extracellular matrix turnover and outflow resistance. , 2009, Experimental eye research.
[31] Bonnie F. Sloane,et al. Caveolin-1 mediates the expression and localization of cathepsin B, pro-urokinase plasminogen activator and their cell-surface receptors in human colorectal carcinoma cells , 2005, Journal of Cell Science.
[32] Zena Werb,et al. Stromal Effects on Mammary Gland Development and Breast Cancer , 2002, Science.
[33] H. Malmgren,et al. The Histological Distribution of Proteinase and Peptidase Activity in Solid Tumor Transplants: A Histochemical Study of the Enzymic Characteristics of the Different Tumor Cell Types , 1960, Acta radiologica. Supplementum.
[34] Bonnie F. Sloane,et al. Imaging Proteolysis by Living Human Glioma Cells , 2001 .
[35] Bonnie F. Sloane,et al. Properties of a plasma membrane-associated cathepsin B-like cysteine proteinase in metastatic B16 melanoma variants. , 1987, Cancer research.
[36] R. Weinberg,et al. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. , 2001, Experimental cell research.
[37] K. Hamada,et al. Downregulation of uPARAP mediates cytoskeletal rearrangements and decreases invasion and migration properties in glioma cells , 2011, Journal of Neuro-Oncology.
[38] Christopher M. Overall,et al. Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy , 2006, Nature Reviews Cancer.
[39] M. Kraus,et al. Implications of acidic tumor microenvironment for neoplastic growth and cancer treatment: a computer analysis. , 1996, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[40] P. Loke,et al. Proteases in parasitic diseases. , 2006, Annual review of pathology.
[41] Kami Kim,et al. Location, Location, Location: Trafficking and Function of Secreted Proteases of Toxoplasma and Plasmodium , 2004, Traffic.
[42] J. Pollard,et al. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. , 2006, Cancer research.
[43] C. Rao,et al. Overexpression of caveolin-1 in experimental colon adenocarcinomas and human colon cancer cell lines. , 2004, Oncology reports.
[44] T. Jacks,et al. Technologically advanced cancer modeling in mice. , 2002, Current opinion in genetics & development.
[45] Anne Vincent-Salomon,et al. Epithelial–mesenchymal transition in breast cancer development , 2003 .
[46] Bonnie F. Sloane,et al. Bicarbonate increases tumor pH and inhibits spontaneous metastases. , 2009, Cancer research.
[47] W. Jiang,et al. Type II transmembrane serine protease (TTSP) deregulation in cancer. , 2011, Frontiers in bioscience.
[48] Shuhei Yoshida,et al. Lipid rafts and caveolin-1 are required for invadopodia formation and extracellular matrix degradation by human breast cancer cells. , 2009, Cancer research.
[49] D. Edwards. The cancer degradome : proteases and cancer biology , 2008 .
[50] Sun-Ja Kim,et al. Increased expression of caveolin‐1 and microvessel density correlates with metastasis and poor prognosis in clear cell renal cell carcinoma , 2004, BJU international.
[51] Bonnie F. Sloane,et al. 3D/4D functional imaging of tumor-associated proteolysis: impact of microenvironment. , 2012, Methods in enzymology.
[52] John Condeelis,et al. Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis , 2006, Cell.
[53] A. Elias,et al. Multistep tumorigenesis and the microenvironment , 2004, Breast Cancer Research.
[54] R. McLendon,et al. Acidic stress promotes a glioma stem cell phenotype , 2011, Cell Death and Differentiation.
[55] Philippe Chavrier,et al. Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia , 2009, Journal of Cell Science.
[56] Bonnie F. Sloane,et al. p21-Activated kinase 1 coordinates aberrant cell survival and pericellular proteolysis in a three-dimensional culture model for premalignant progression of human breast cancer. , 2008, Neoplasia.
[57] Bonnie F. Sloane,et al. Functional Imaging of Proteolysis: Stromal and Inflammatory Cells Increase Tumor Proteolysis , 2003 .
[58] Jacco van Rheenen,et al. Collagen-based cell migration models in vitro and in vivo. , 2009, Seminars in cell & developmental biology.
[59] M. Roizen,et al. Hallmarks of Cancer: The Next Generation , 2012 .
[60] M. Lisanti,et al. Caveolin-1, a putative tumour suppressor gene. , 2001, Biochemical Society transactions.
[61] L. Matrisian,et al. The other side of MMPs: Protective roles in tumor progression , 2007, Cancer and Metastasis Reviews.
[62] H. Haller,et al. Urokinase-receptor-mediated phenotypic changes in vascular smooth muscle cells require the involvement of membrane rafts. , 2009, The Biochemical journal.
[63] C. Peters,et al. Deficiency for the cysteine protease cathepsin L promotes tumor progression in mouse epidermis , 2010, Oncogene.
[64] Mina J Bissell,et al. Modeling dynamic reciprocity: engineering three-dimensional culture models of breast architecture, function, and neoplastic transformation. , 2005, Seminars in cancer biology.
[65] B. Nielsen,et al. The myofibroblast is the predominant plasminogen activator inhibitor-1-expressing cell type in human breast carcinomas. , 2003, The American journal of pathology.
[66] H. Yamaguchi,et al. Membrane lipids in invadopodia and podosomes: Key structures for cancer invasion and metastasis , 2010, Oncotarget.
[67] J. Haveman,et al. The relevance of tumour pH to the treatment of malignant disease. , 1984, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[68] R. Knuechel,et al. Tumor‐associated fibroblasts recruit blood monocytes into tumor tissue , 2003, European journal of immunology.
[69] B. Finlay,et al. The caspase-1 inflammasome: a pilot of innate immune responses. , 2008, Cell host & microbe.
[70] B. O'connor,et al. Seprase: an overview of an important matrix serine protease. , 2008, Biochimica et biophysica acta.
[71] Meenhard Herlyn,et al. Axis of evil: molecular mechanisms of cancer metastasis , 2003, Oncogene.
[72] K. Jeong,et al. Metabolic consequences of a reversed pH gradient in rat tumors. , 1994, Cancer research.
[73] J. Hodgson,et al. TIMP-1 Alters Susceptibility to Carcinogenesis , 2004, Cancer Research.
[74] A. Poole,et al. Differences in secretion of the proteinase cathepsin B at the edges of human breast carcinomas and fibroadenomas , 1978, Nature.
[75] Bonnie F. Sloane,et al. Live-cell imaging demonstrates extracellular matrix degradation in association with active cathepsin B in caveolae of endothelial cells during tube formation. , 2009, Experimental cell research.
[76] O. Warburg,et al. THE METABOLISM OF TUMORS IN THE BODY , 1927, The Journal of general physiology.
[77] M. Schmitt,et al. Interdependence of kallikrein-related peptidases in proteolytic networks , 2010, Biological chemistry.
[78] H. Rochefort,et al. The 52-kDa estrogen-induced protein secreted by MCF7 cells is a lysosomal acidic protease. , 1986, Biochemical and biophysical research communications.
[79] A. Recklies,et al. Secretion of proteinases from malignant and nonmalignant human breast tissue. , 1980, Cancer research.
[80] Elise C. Kohn,et al. The microenvironment of the tumour–host interface , 2001, Nature.
[81] J. Pollard,et al. Distinct role of macrophages in different tumor microenvironments. , 2006, Cancer research.
[82] Bonnie F. Sloane,et al. Cell surface complex of cathepsin B/annexin II tetramer in malignant progression. , 2000, Biochimica et biophysica acta.
[83] M. Robinson,et al. Caveolin-1 expression is associated with high-grade bladder cancer. , 2001, Urology.
[84] Sarah Boyd,et al. PMAP: databases for analyzing proteolytic events and pathways , 2008, Nucleic Acids Res..
[85] R. Williamson,et al. Role of TIMPs (tissue inhibitors of metalloproteinases) in pericellular proteolysis: the specificity is in the detail. , 2003, Biochemical Society symposium.
[86] H. Kobayashi,et al. Effects of membrane-associated cathepsin B on the activation of receptor-bound prourokinase and subsequent invasion of reconstituted basement membranes. , 1993, Biochimica et biophysica acta.
[87] G. Stenbeck. Formation and function of the ruffled border in osteoclasts. , 2002, Seminars in cell & developmental biology.
[88] A. Krüger,et al. Avoiding spam in the proteolytic internet: future strategies for anti-metastatic MMP inhibition. , 2010, Biochimica et biophysica acta.
[89] Jayanta Debnath,et al. The Role of Apoptosis in Creating and Maintaining Luminal Space within Normal and Oncogene-Expressing Mammary Acini , 2002, Cell.
[90] Kornelia Polyak,et al. Do Myoepithelial Cells Hold the Key for Breast Tumor Progression? , 2005, Journal of Mammary Gland Biology and Neoplasia.
[91] M. Gottesman,et al. The major excreted protein of transformed fibroblasts is an activable acid-protease. , 1986, The Journal of biological chemistry.
[92] Bonnie F. Sloane,et al. Pericellular cathepsin B and malignant progression , 2003, Cancer and Metastasis Reviews.
[93] Y. Lazebnik,et al. Cell fusion: a hidden enemy? , 2003, Cancer cell.
[94] Bonnie F. Sloane,et al. Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. , 1994, Cancer research.
[95] K. Almholt,et al. Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. , 1998, Current opinion in cell biology.
[96] Bonnie F. Sloane,et al. Cell-surface cathepsin B: understanding its functional significance. , 2003, Current topics in developmental biology.
[97] B. Nielsen,et al. Intracellular collagen degradation mediated by uPARAP/Endo180 is a major pathway of extracellular matrix turnover during malignancy , 2005, The Journal of cell biology.
[98] B. Nielsen,et al. Extracellular Proteolysis in Transgenic Mouse Models of Breast Cancer , 2007, Journal of Mammary Gland Biology and Neoplasia.
[99] S. Fine,et al. Elevated expression of caveolin-1 in adenocarcinoma of the colon. , 2001, American journal of clinical pathology.
[100] Natarajan Raghunand,et al. In vivo imaging of extracellular pH using 1H MRSI , 1999, Magnetic resonance in medicine.
[101] L. Coussens,et al. Protective role of cathepsin L in mouse skin carcinogenesis , 2012, Molecular carcinogenesis.
[102] S. Zucker,et al. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment , 2000, Oncogene.
[103] Z. Werb,et al. New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.
[104] A. Lardner. The effects of extracellular pH on immune function , 2001, Journal of leukocyte biology.
[105] P. Saftig,et al. Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function , 2009, Nature Reviews Molecular Cell Biology.
[106] Bonnie F. Sloane,et al. Phorbol ester activation of a proteolytic cascade capable of activating latent TGF-β: A process initiated by the exocytosis of cathepsin B , 2002 .
[107] Bonnie F. Sloane,et al. Human Procathepsin B Interacts with the Annexin II Tetramer on the Surface of Tumor Cells* , 2000, The Journal of Biological Chemistry.
[108] M. Kattan,et al. Elevated expression of caveolin is associated with prostate and breast cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[109] J. Pollard,et al. Requirement of macrophages and eosinophils and their cytokines/chemokines for mammary gland development , 2002, Breast Cancer Research.
[110] Mina J Bissell,et al. Modeling tissue-specific signaling and organ function in three dimensions , 2003, Journal of Cell Science.
[111] D. Cunningham,et al. Matrix metalloproteinase inhibitors--an emphasis on gastrointestinal malignancies. , 2003, Critical reviews in oncology/hematology.
[112] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[113] Neil D. Rawlings,et al. MEROPS: the peptidase database , 2009, Nucleic Acids Res..
[114] R. Buccione,et al. Aiming for invadopodia: organizing polarized delivery at sites of invasion. , 2010, Trends in cell biology.
[115] Stéphanie Balor,et al. Macrophage podosomes go 3D. , 2011, European journal of cell biology.
[116] M. Ebert,et al. Caveats of caveolin-1 in cancer progression. , 2008, Cancer letters.
[117] F. Gauffre,et al. Matrix Architecture Dictates Three-Dimensional Migration Modes of Human Macrophages: Differential Involvement of Proteases and Podosome-Like Structures , 2009, The Journal of Immunology.
[118] Bonnie F. Sloane,et al. Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasion , 2011, Breast Cancer Research.
[119] F. Saltel,et al. Actin cytoskeletal organisation in osteoclasts: a model to decipher transmigration and matrix degradation. , 2008, European journal of cell biology.
[120] C. López-Otín,et al. Expanding the complexity of the human degradome: polyserases and their tandem serine protease domains. , 2007, Frontiers in bioscience : a journal and virtual library.
[121] M. Barcellos-Hoff,et al. The not-so innocent bystander: the microenvironment as a therapeutic target in cancer , 2003, Expert opinion on therapeutic targets.
[122] G. Taraboletti,et al. Cathepsin B mediates the pH-dependent proinvasive activity of tumor-shed microvesicles. , 2008, Neoplasia.
[123] Lien Wp,et al. Imaging matrix metalloproteinase expression in tumors. , 2003 .
[124] Bonnie F. Sloane,et al. Cathepsin B and its role(s) in cancer progression. , 2003, Biochemical Society symposium.
[125] R. Hill,et al. Glucose starvation and acidosis: effect on experimental metastatic potential, DNA content and MTX resistance of murine tumour cells. , 1991, British Journal of Cancer.
[126] B. Fingleton,et al. Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.
[127] C. Isacke,et al. Membrane type-1 matrix metalloproteinase activity is regulated by the endocytic collagen receptor Endo180 , 2009, Journal of Cell Science.
[128] I. Fidler,et al. Acidic pH-induced elevation in interleukin 8 expression by human ovarian carcinoma cells. , 2000, Cancer research.
[129] M. Drab,et al. Loss of Caveolae, Vascular Dysfunction, and Pulmonary Defects in Caveolin-1 Gene-Disrupted Mice , 2001, Science.
[130] S. Zucker,et al. Selective matrix metalloproteinase (MMP) inhibitors in cancer therapy: Ready for prime time? , 2009, Cancer biology & therapy.
[131] Bonnie F. Sloane,et al. Imaging proteolysis by living human breast cancer cells. , 2000, Neoplasia.
[132] Jayanta Debnath,et al. Modelling glandular epithelial cancers in three-dimensional cultures , 2005, Nature Reviews Cancer.
[133] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[134] Y. Okamoto,et al. Caveolin-1 mediates tumor cell migration and invasion and its regulation by miR-133a in head and neck squamous cell carcinoma. , 2010, International journal of oncology.
[135] Andrew V. Nguyen,et al. Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy , 2001, The Journal of experimental medicine.
[136] S. Wiseman,et al. Caveolin-1 in tumor progression: the good, the bad and the ugly , 2008, Cancer and Metastasis Reviews.
[137] D. Glick. The histological distribution of proteinase and peptidase activity in solid tumor transplants: By B. Sylvén and H. Malmgren. Acta Radiologica, Suppl. 154, Stockholm, 1957. 124 pp. Price 30 Sw. Kr , 1958 .
[138] G. Sledge,et al. Activity of biphenyl matrix metalloproteinase inhibitor BAY 12-9566 in a human breast cancer orthotopic model , 2004, Clinical & Experimental Metastasis.
[139] R. Jain,et al. Acidic Extracellular pH Induces Vascular Endothelial Growth Factor (VEGF) in Human Glioblastoma Cells via ERK1/2 MAPK Signaling Pathway , 2002, The Journal of Biological Chemistry.
[140] D. Waisman,et al. S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors. , 2005, Frontiers in bioscience : a journal and virtual library.
[141] R. Khokha,et al. The Role of Tissue Inhibitors of Metalloproteinases in Tumorigenesis and Metastasis , 2008, Critical reviews in clinical laboratory sciences.
[142] L. Matrisian,et al. Molecular imaging of proteolytic activity in cancer , 2003, Journal of cellular biochemistry.
[143] B. Hempstead,et al. Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo. , 2004, The Journal of clinical investigation.
[144] K. Bakunts,et al. Vacuolar H+-ATPase in human breast cancer cells with distinct metastatic potential: distribution and functional activity. , 2004, American journal of physiology. Cell physiology.
[145] J. Rak,et al. Host microenvironment in breast cancer development: Inflammatory and immune cells in tumour angiogenesis and arteriogenesis , 2003, Breast Cancer Research.
[146] Robert J Gillies,et al. Contributions of cell metabolism and H+ diffusion to the acidic pH of tumors. , 2003, Neoplasia.
[147] Fibroblast hepatocyte growth factor promotes invasion of human mammary ductal carcinoma in situ. , 2009, Cancer research.
[148] 汪翼,et al. Caveolin-1和肿瘤 , 2004 .
[149] Bonnie F. Sloane,et al. Cysteine cathepsins: multifunctional enzymes in cancer , 2006, Nature Reviews Cancer.
[150] Bonnie F. Sloane,et al. Molecular Regulation of Human Cathepsin B: Implication in Pathologies , 2003, Biological chemistry.
[151] G. Beznoussenko,et al. Invadopodia biogenesis is regulated by caveolin‐mediated modulation of membrane cholesterol levels , 2009, Journal of cellular and molecular medicine.
[152] Miss A.O. Penney. (b) , 1974, The New Yale Book of Quotations.
[153] P. Rosenthal,et al. Cysteine proteases of malaria parasites. , 2004, International journal for parasitology.
[154] J. Joyce,et al. Proteolytic networks in cancer. , 2011, Trends in cell biology.
[155] J. Abbruzzese,et al. Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells , 2001, Oncogene.
[156] Jiyun V Kim,et al. Annexin II: a plasminogen-plasminogen activator co-receptor. , 2002, Frontiers in bioscience : a journal and virtual library.
[157] Rakesh K. Jain,et al. Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation , 1997, Nature Medicine.
[158] Christopher M Overall,et al. Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. , 2006, Nature reviews. Cancer.
[159] P. Sträuli,et al. Immunofluorescent studies on the occurrence of cathepsin B1 at tumor cell surfaces , 1975, Virchows Archiv. B, Cell pathology.
[160] W. Muller,et al. Ets2-dependent microenvironmental support of mouse mammary tumors , 2005, Oncogene.
[161] T. Jacks,et al. Cancer Modeling in the Modern Era Progress and Challenges , 2002, Cell.
[162] D. Turk,et al. Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors. , 1997, Biological chemistry.
[163] F. Blasi,et al. The urokinase receptor: Focused cell surface proteolysis, cell adhesion and signaling , 2010, FEBS letters.
[164] R. Gillies,et al. Tumorigenic 3T3 cells maintain an alkaline intracellular pH under physiological conditions. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[165] Sheila J. Jones,et al. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[166] K. Almholt,et al. Stromal cell involvement in cancer. , 2003, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[167] Fred R. Miller,et al. Malignant MCF10CA1 Cell Lines Derived from Premalignant Human Breast Epithelial MCF10AT Cells , 2004, Breast Cancer Research and Treatment.
[168] L. Coussens,et al. MMP9 potentiates pulmonary metastasis formation. , 2002, Cancer cell.
[169] G. Taraboletti,et al. Bioavailability of VEGF in tumor-shed vesicles depends on vesicle burst induced by acidic pH. , 2006, Neoplasia.
[170] W. T. Chen,et al. A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells. , 1994, Cancer research.
[171] F. Miller. Xenograft Models of Premalignant Breast Disease , 2000, Journal of Mammary Gland Biology and Neoplasia.
[172] Kenneth M. Yamada,et al. Dynamic membrane remodeling at invadopodia differentiates invadopodia from podosomes. , 2011, European journal of cell biology.
[173] Bonnie F. Sloane,et al. Lysosomal cathepsin B participates in the podosome-mediated extracellular matrix degradation and invasion via secreted lysosomes in v-Src fibroblasts (Cancer Research (2008) 68, (9147-9156)) , 2009 .
[174] F. Miller,et al. MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ. , 2000, Journal of the National Cancer Institute.
[175] Bonnie F. Sloane,et al. Cysteine cathepsin non-inhibitory binding partners: modulating intracellular trafficking and function , 2007, Biological chemistry.
[176] Pan‐Chyr Yang,et al. Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation. , 2002, The American journal of pathology.
[177] C. Overall,et al. Matrix metalloproteinases: what do they not do? New substrates and biological roles identified by murine models and proteomics. , 2010, Biochimica et biophysica acta.
[178] Alexander Varshavsky,et al. The ubiquitin system. , 1998, Annual review of biochemistry.
[179] C. Myers,et al. Breast cancer-induced angiogenesis: multiple mechanisms and the role of the microenvironment , 2003, Breast Cancer Research.
[180] A. Ben-Baruch,et al. Host microenvironment in breast cancer development: Inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor–microenvironment interactions , 2002, Breast Cancer Research.
[181] Bonnie F. Sloane,et al. Visualizing Protease Activity in Living Cells: From Two Dimensions to Four Dimensions , 2008, Current protocols in cell biology.